Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check4 days agoChange DetectedThe location entry for Zaporizhzhia, Ukraine, 69005 was updated to Zaporizhzhya, Ukraine, 69005 in the study locations.SummaryDifference0.0%

- Check12 days agoChange DetectedEnrollment status updated to indicate the study is no longer recruiting participants, reflecting completion of enrollment. New navigation items for reading the study record, common questions, and joining the study were added, along with updated bibliographic references.SummaryDifference0.1%

- Check19 days agoChange DetectedA new citation for EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF trial (JAMA Cardiol 2026) was added to Publications, and the earlier online-ahead-of-print entry was removed, reflecting an update to the trial’s bibliographic references.SummaryDifference0.0%

- Check26 days agoChange DetectedTwo new publications were added to the Publications section of the study record. An existing citation was updated to reflect final bibliographic details (publication date and page range) for the prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trial.SummaryDifference0.0%

- Check33 days agoChange DetectedA new citation for a plain-language review of finerenone in heart failure with mildly reduced or preserved ejection fraction has been added, and the page revision was updated to v3.5.4.SummaryDifference0.0%

- Check47 days agoChange DetectedThe Taiwan site entry was updated from Taoyuan District to Taoyuan city, clarifying the location as Taoyuan, Taiwan, 33305 for that study site.SummaryDifference0.0%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.